Utility of Biomarkers in Prediction of Response to Ablative Therapy in Barrett's Esophagus

This publication has 61 references indexed in Scilit:

• Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett’s Esophagus
  Gastroenterology, 2007
• The Development of a Fluorescence in Situ Hybridization Assay for the Detection of Dysplasia and Adenocarcinoma in Barrett's Esophagus
  The Journal of Molecular Diagnostics, 2006
• Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett’s Esophagus
  Clinical Gastroenterology and Hepatology, 2006
• Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial
  Gastrointestinal Endoscopy, 2005
• International, multicenter, partially blinded, randomised study of the efficacy of photodynamic therapy (PDT) using porfimer sodium (POR) for the ablation of high-grade dysplasia (HGD) in barrett's esophagus (BE): Results of 24-month follow-up
  Gastroenterology, 2003
• Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett[apos ]s esophagus
  Gastrointestinal Endoscopy, 2001
• Frequent c-mycAmplification in High-Grade Dysplasia and Adenocarcinoma in Barrett Esophagus
  American Journal of Clinical Pathology, 2001
• p53 Mutations in Barrett's esophagus predict poor response to photodynamic therapy
  Gastroenterology, 2001
• Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region
  The American Journal of Pathology, 1998
• p53 Status and the Efficacy of Cancer Therapy in Vivo
  Science, 1994